D. Iarossi

发表

The preferential occurrence of FLT3‐TKD mutations in inv(16) AML and impact on survival outcome: a combined analysis of 1053 core‐binding factor AML patients

Anna L. Brown, R. D'Andrea, I. Lewis, 2013, British journal of haematology.

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

Anna L. Brown, Mahmoud A. Bassal, U. Roessner, 2022, Nature Communications.

A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm

R. D'Andrea, A. Wee, I. Lewis, 2017, Scientific Reports.

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations

R. D'Andrea, I. Lewis, L. To, 2013, Leukemia.

Interleukin‐3‐mediated regulation of β‐catenin in myeloid transformation and acute myeloid leukemia

G. Brumatti, Angel F. Lopez, P. Ekert, 2014, Journal of leukocyte biology.

Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.

Angel F. Lopez, H. Ramshaw, I. Lewis, 2017, Blood.

Targeting sphingosine kinase 1 induces MCL 1 dependent cell death in acute myeloid leukemia Running title : Targeting sphingosine kinase 1 in acute myeloid leukemia

Pitman, Angel F. Lopez, H. Ramshaw, 2016 .

A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm

A. Wee, I. Lewis, H. Scott, 2017, Scientific Reports.

Investigation of a Novel Cyclin-Dependent-Kinase (CDK) Inhibitor Cdki-73 As an Effective Treatment Option for MLL-AML

I. Lewis, L. To, Shudong Wang, 2015 .